Recombinant factor VIII (rEVO Biologics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant factor VIII (rEVO Biologics)
Drug Alias NameRecombinant factor VIII (GTC)Recombinant factor VIII (Progenics)Factane
ClassificationBiologics
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRevo Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRevo Biologics Inc
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A